EP3638241
PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.6.2018:
25.5.2022:
18817811.5
:
14.6.2038
:
PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF
15.6.2018
25.5.2022
:
Beta Pharma, Inc.:
1000 N. West Street Suite 1200, Wilmington, DE 19801, US
:
GRECO, Michael, Nicholas:
Lansdale PA 19446, US
:
COSTANZO, Michael, John:
Warminster PA 18974, US
:
GREEN, Michael, Alan:
Easton PA 18040, US
:
PENG, Jirong:
Mequon WI 53097, US
:
WILDE, Victoria, Lynn:
Montclair NJ 07042, US
:
ZHANG, Don:
Princeton NJ 08540, US
:
201762521007 P:
16.6.2017:
US
:
US2018037744:
15.6.2018
:
A61K 31/506, A61K 31/404, C07D 239/42, C07D 401/04